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Previews
Enter Xu et al. (2004) who describe in an elegant studyNorrin and Frizzled:
in the March 19th issue of Cell yet another secretedA New Vein for the Eye activator of Wnt/-catenin signaling, the protein product
of the Norrie disease gene (NDP), called Norrin (Berger
and Ropers, 2001). Their interest in Norrin was triggered
by the similarity of phenotypes between Fz4 mouse mu-
tants and Norrie disease patients. Norrie disease (ND)
The Wnt signaling network is arguably one of the most
is a X-linked congenital retinal dysplasia that can be
complex molecular modules by which cells communi-
accompanied by hearing loss and mental retardation.cate. Though we become accustomed to novel com-
Over 70 distinct NDP mutations have been identified inponents, the discovery of an unexpected Wnt receptor
patients with ND (Berger and Ropers, 2001). Similar toligand, Norrin, is surprising even to the connoisseur.
ND patients, mice mutant for the NDP ortholog show
absence of intraretinal capillaries and progressive loss
Wnts bind to cell surface receptors and trigger activa- of vessels in the cochlea (Rehm et al., 2002).
tion of at least two, likely three pathways (http://www. Congenital retinal defects are also seen in another
stanford.edu/rnusse/wntwindow.html). The best-char- congenital disease, FEVR (familial exudative vitreoreti-
acterized signaling cascade is the canonical, or Wnt/ nopathy), where patients show incomplete vasculariza-
-catenin pathway. Activation of the pathway by a Wnt tion of the retina. Since one FEVR locus has recently
protein results in -catenin being stabilized; it then been shown to correspond to the human Fz4 gene (Robi-
enters the nucleus, where, with members of the “high- taille et al., 2002), Xu et al. went back to their Fz4/
mobility-group” protein family, it activates the expres- mice and discovered vascular defects in mutant retina
sion of specific genes to control cell fate. Another path- which resemble those described in Ndp mutant mice.
way engaged by Wnts is the planar cell polarity pathway Adding to this the observation that patients and mice
(PCP), which does not involve -catenin but employs with mutations in the Wnt coreceptor LRP5 also show
small GTPases of the rho/cdc42 family to activate jun vascular eye defects, they tested if Norrin might directly
kinase. A third Wnt-triggered pathway, which may be play a role in Wnt signaling. The biochemical function
partly overlapping with the PCP pathway, is the Wnt/ of the Norrin protein was unknown, but it encodes a
Ca2 cascade, which mobilizes Ca2 ions within cells secretory protein containing a cysteine-knot motif. Nor-
and thereby activates certain Ca2-dependent enzymes, rin turns out to be a high-affinity ligand for Fz4, which
including protein kinase C. One feature that all three can activate Wnt/-catenin signaling. The interaction is
pathways have in common is that they require Wnt re- of surprisingly high specificity; of six Fz proteins Norrin
ceptors of the Frizzled (Fz) family of seven-transmem- interacts only with Fz4. Norrin shares a number of prop-
brane proteins. These receptors have N-terminal extra- erties with Wnt proteins; Norrin binds to the CRD of Fz4;
cellular domains termed cystein rich domains (CRD), it is poorly secreted and is mostly associated with the
which mediate high-affinity interaction between the 19 extracellular matrix, acting as a short-range signal; Nor-
or so Wnt and 10 Fz proteins. Different Wnts have differ- rin does not bind directly to LRP6. However, unlike Wnts,
ent affinities for various Fz and may engage different which robustly activate Wnt/-catenin signaling with Fz
pathways, generating a great complexity of signaling in the absence of cotransfected LRPs, Norrin requires
possibilities.
cotransfection with LRP5/6. This raises the possibility
In addition, Wnts require coreceptors of the lipo-
that Norrin interacts in a ternary complex with Fz and
protein receptor related protein 5/6 class (LRP5/6),
LRPs, as has been suggested for Wnts.which are specifically coupling to the Wnt/-catenin path-
While the authors have shown that Norrin/Fz4 canway, likely by forming a ternary complex with Wnt and Fz
activate the Wnt/-catenin pathway in vitro and likelyproteins (http://www.stanford.edu/rnusse/wntwindow.
in vivo, one should be open to the possibility that thishtml). Recently, Drosophila Wnt5 was shown to engage
ligand may also employ the Wnt/PCP or the Wnt/Ca2yet another transmembrane receptor, the tyrosine ki-
pathways, given a matching Fz. A precedent is XWnt5a,nase Derailed (Yoshikawa et al., 2003). Adding to this
which activates Wnt/-catenin signaling with human Fz5complexity is the fact that Wnts are not the only secreted
and the Wnt/Ca2 pathway together with rat Fz2.factors able to activate the -catenin pathway. Secreted
It is intriguing that three genes—NDP, Fz4, andFrizzled related protein 1 can activate Wnt/-catenin
LRP5—acting in the Wnt pathway have now been impli-signaling at low dose while it inhibits at high dose (Uren
cated in vascularization of the retina, which suggestset al., 2000). Dkk2, a member of the Dickkopf family of
that the Wnt/-catenin pathway may play a wider rolesecreted Wnt antagonists, binds and activates LRP6
in vascular development. Indeed, Fz5 mutants show de-but, in the presence of its coreceptor Kremen, inhibits
fects in placental vasculogenesis (Ishikawa et al., 2001),Wnt/-catenin signaling (Mao and Niehrs, 2003). A Dkk-
as do mutants of the lipid phosphatase LPP3, which alsounrelated LRP6 ligand, Wise, can also activate or inhibit
regulates Wnt/-catenin signaling (Escalante-Alcalde etWnt signaling in a context-dependent manner (Itasaki
et al., 2003). al., 2003). The implication of Wnt/-catenin signaling in
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stem cells. However, these data also raised many ques-Revisiting the Bulge
tions about bulge cell heterogeneity and the cellular and
molecular relationships of the hair follicle to interfollicu-
lar stem cells. The two recent papers are nicely comple-
mentary in documenting isolation, from the bulge region,Two recent papers—one from the group of Elaine
of slowly cycling cells with high proliferative capacity,Fuchs in Science and the other from the group of
multipotentiality (capacity to contribute to the three dis-George Costarelis in Nature Biotechnology—on the
tinct cutaneous epidermal lineages), and transplantabil-isolation and multipotentiality of adult hair follicle stem
ity. Together they suggest that the long-awaited andcells catapult us ahead in our understanding of epider-
elusive hair follicle stem cell has been found.mal and hair follicle lineages.
The two groups reached similar conclusions, but used
somewhat different genetic strategies to track and iso-
Although hair is presumed to have evolved as a survival late a subpopulation of cells from the bulge. Based on
vehicle, in contemporary society it clearly also plays a their assumption that bulge stem cells would uniquely be
tremendous role in self-esteem and sexual communica- both slow-cycling and active for a keratinocyte-specific
tion. It is therefore not surprising that hair care has be- promoter, Fuchs’ group engineered transgenic mice to
come a multi-billion-dollar industry with tremendous express histone H2B–green fluorescent protein (GFP)
stock market consequences. In spite of this socioeco- controlled by a tetracycline (tet)-responsive regulatory
nomic prominence, our understanding of the hair follicle element and crossed them to mice harboring a keratin
lineage and our ability to manipulate it remain rather 5 (K5) promoter–tet repressor–VP16 transgene. Four
rudimentary. The identification and characterization of weeks of tet treatment of the double transgenic offspring
hair follicle stem cells, as well as what regulates their with tet–controlled regulation restricted to skin epithe-
commitment and differentiation, has generally lagged lium selected for a low frequency (1%) of slowly cycling
behind other adult stem cells and lineages. However, bulge cells. Cotsarelis’ group, on the other hand, used
two recent papers (Tumbar et al., 2004; Morris et al., a keratin 1-15 (K15) promoter fragment to target mouse
2004) move us toward closing this gap. bulge cells with an inducible Cre recombinase construct
How did we get here? It has long been known that skin or with the gene encoding GFP to mark bulge cells for
and its appendages, including hair, have the capacity to lineage analysis in vivo and isolation, respectively. Fur-
renew throughout life, implying the existence of a large ther characterization of either of the GFP-positive popu-
reservoir of putative stem cells. Over 10 years ago, Cot- lations on the basis of a number of phenotypic and
sarelis et al. (1990) made a seminal contribution by dem- functional properties in vitro and in vivo indicate that the
onstrating the location of the infrequently cycling label- cells meet many of the hallmark definitions of stem cells.
retaining cells (LRCs) in the bulge region of the outer What evidence was provided that any of the cells
root sheath of the hair shaft (see Figure 1). Not only cells identified in either study are multipotential and generate
with the highest label-retaining capacity but also those or regenerate hair follicles and other cutaneous lineages,
with the highest clonogenicity in vitro in the mammalian a feature attributed to bulge stem cells (Taylor et al.,
epidermis occur in or near the bulge region. Other exper- 2000; Oshima et al. 2001)? This is a key question given
imental manipulations provided evidence that the bulge that there is evidence both for multipotent cells as well
region contains multipotent stem cells that are more as more restricted progenitor cells, i.e., cells that give
rise to, for example, only the hair follicle or only theproliferative and potent than interfollicular epidermal
